Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
T. Cai, S. Mazzoli, G. Nesi, V. Boddi, N. Mondaini & R. Bartoletti. (2009) 14-Day Prulifloxacin Treatment of Acute Uncomplicated cystitis in Women with Recurrent Urinary Tract Infections: A Prospective, Open-Label, Pilot Trial With 6-Month Follow-Up. Journal of Chemotherapy 21:5, pages 535-541.
Read now
Read now
Articles from other publishers (20)
Tyler J. Brehm, Barbara W. Trautner & Prathit A. Kulkarni. (2023) Acute and Chronic Infectious Prostatitis in Older Adults. Infectious Disease Clinics of North America 37:1, pages 175-194.
Crossref
Crossref
A. Ferlin, A. E. Calogero, C. Krausz, F. Lombardo, D. Paoli, R. Rago, C. Scarica, M. Simoni, C. Foresta, V. Rochira, E. Sbardella, S. Francavilla & G. Corona. (2022) Management of male factor infertility: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS). Journal of Endocrinological Investigation 45:5, pages 1085-1113.
Crossref
Crossref
Vittorio Magri, Gianpaolo Perletti, Tommaso Cai, Konstantinos Stamatiou, Alberto Trinchieri & Emanuele Montanari. (2019) Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study. Chemotherapy 64:1, pages 8-16.
Crossref
Crossref
Gianpaolo Perletti & Vittorio Magri. 2016. Prostatitis and Its Management. Prostatitis and Its Management
33
48
.
Catherine C. McGowan & John Krieger. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
1381
1387.e2
.
David C. Hooper & Jacob Strahilevitz. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
419
439.e8
.
Gian Maria Busetto, Riccardo Giovannone, Matteo Ferro, Stefano Tricarico, Francesco Del Giudice, Deliu Victor Matei, Ottavio De Cobelli, Vincenzo Gentile & Ettore De Berardinis. (2014) Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®). BMC Urology 14:1.
Crossref
Crossref
Salvatore Marco Recupero, Riccardo Bientinesi, Nazario Foschi, Marco Racioppi, Pier Francesco Bassi & Emilio Sacco. (2014) Antibiotic Prophylaxis in Urology. Urologia Journal 81:4, pages 209-217.
Crossref
Crossref
Zhoujun Shen, Shan Zhong, Yu Zhu, Yuan Shao, Wei He, Chenjing Zhang, Xianjin Wang, Tao Li, Sakaliya & Hongchao He. 2014. Infectious Microecology. Infectious Microecology
377
409
.
D. E. Karageorgopoulos, S. Maraki, A. C. Vatopoulos, G. Samonis, G. C. Schito & M. E. Falagas. (2013) Antimicrobial activity of prulifloxacin in comparison with other fluoroquinolones against community-acquired urinary and respiratory pathogens isolated in Greece. European Journal of Clinical Microbiology & Infectious Diseases 32:11, pages 1417-1422.
Crossref
Crossref
Gianpaolo Perletti, Emanuela Marras, Florian ME Wagenlehner & Vittorio Magri. (2013) Antimicrobial therapy for chronic bacterial prostatitis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Petros I. Rafailidis, Konstantinos A. Polyzos, Konstantinos Sgouros & Matthew E. Falagas. (2011) Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections. International Journal of Antimicrobial Agents 37:4, pages 283-290.
Crossref
Crossref
. (2011) Clinical Guideline for the Diagnosis and Treatment of Urinary Tract Infections: Asymptomatic Bacteriuria, Uncomplicated & Complicated Urinary Tract Infections, Bacterial Prostatitis. Infection and Chemotherapy 43:1, pages 1.
Crossref
Crossref
JOHN N. KRIEGER. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
1521
1527
.
DAVID C. HOOPER & JACOB STRAHILEVITZ. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
487
510
.
Rocco Damiano, Marco De Sio, Giuseppe Quarto, Giuseppe Di Lorenzo, Sisto Perdonà, Italo M. Palumbo, Giuseppina Azzarito, Francesco Giugliano & Riccardo Autorino. (2009) Short-term administration of prulifloxacin in patients with nonmuscle-invasive bladder cancer: an effective option for the prevention of bacillus Calmette-Guérin-induced toxicity?. BJU International 104:5, pages 633-639.
Crossref
Crossref
Gianluca Giannarini & Riccardo Autorino. (2009) Re: Serenoa repens associated with Urtica dioica (ProstaMEV®) and curcumin and quercitin (FlogMEV®) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study. International Journal of Antimicrobial Agents 34:3, pages 283-284.
Crossref
Crossref
Thomas R. Fritsche, Douglas J. Biedenbach & Ronald N. Jones. (2009) Antimicrobial Activity of Prulifloxacin Tested against a Worldwide Collection of Gastroenteritis-Producing Pathogens, Including Those Causing Traveler's Diarrhea. Antimicrobial Agents and Chemotherapy 53:3, pages 1221-1224.
Crossref
Crossref
Gianluca GiannariniCarlo TasciniCesare Selli. (2009) Prulifloxacin: clinical studies of a broad-spectrum quinolone agent. Future Microbiology 4:1, pages 13-24.
Crossref
Crossref
Claudio Giberti, Fabrizio Gallo, Maria T Rosignoli, Alessandro Ruggieri, Simona Barattè, Rossella Picollo & Paolo Dionisio. (2009) Penetration of Orally Administered Prulifloxacin into Human Prostate Tissue. Clinical Drug Investigation 29:1, pages 27-34.
Crossref
Crossref